Bewertung: 0 von 5 Sternen
0 Bewertungen
Wird geladen
RO![]()
author
Robert L Obenchain
Robert L. (Bob) Obenchain is a biostatistician and pharmaco-epidemiologist specializing in observational comparative effectiveness research, heterogeneous treatment effects (personalized/individual...mehr sehenRobert L. (Bob) Obenchain is a biostatistician and pharmaco-epidemiologist specializing in observational comparative effectiveness research, heterogeneous treatment effects (personalized/individualized medicine) and risk assessment-mitigation strategies for marketed pharmaceutical products. He is currently the Principal Consultant for Risk Benefit Statistics, LLC, in Indianapolis, IN. Bob received his BS in Engineering-Science from Northwestern and his PhD in Mathematical Statistics from UNC-Chapel Hill. Bob spent 16 years in research at AT&T Bell Labs, followed by an associate director role in non-clinical statistics at GlaxoSmithKline, before spending 17 years at Eli Lilly as a Sr. Research Advisor and Group Leader of statistical consulting in Health Outcomes Research.
Bob was elected as a Fellow of American Statistical Association (ASA) in 1997. He has also served on a variety of statistical methodological roles for SAMSI, NISS, and FNIH, and as an adjunct Professor of Biostatistics at the University of North Carolina and the Indiana University Medical School.weniger sehen
Bücher von Robert L Obenchain
Real World Health Care Data Analysis: Causal Methods and Implementation Using SAS